When Chase announced in January that it would close customer service accounts and terminate all bank accounts for people under the age of 30, many thought it would shut the company down.But Chase said it had more work to do, and it's already in the process of closing customer service lines.That's the good news, but it's also the bad news, because it's still very much a service company and it still...
Fitbit says it has reached a $2 billion deal with startup Insys, which provides data analytics for the fitness trackers.
Insys, based in San Francisco, will offer Fitbit a cloud-based platform that will allow it to access its vast database of health data.
Fitbit, which recently acquired Jawbone, is the first wearable startup to partner with a tech firm that provides data to companies like Insys.
The deal also includes Fitbit’s fitness tracker, the Fitbit Charge, and the FitBit Blaze, the first of which will be available in the United States and Canada on Nov. 12.
The Fitbit deal comes amid growing attention from investors about the company’s health trackers, which offer the ability to track a person’s heart rate, blood pressure and oxygen levels.
The company has faced criticism from regulators and consumer advocates who have called for more regulation around the use of data in health products.
Fitness tracking has been the subject of much scrutiny since the Fitbits, which can track distance, pace and calories burned, were introduced in 2011.
Fitbits use a battery pack that is attached to a wristband that can be worn by the wearer, and have been criticized for selling users unnecessary data about their health and the environment.
Fitbit CEO Jeremy Horowitz said Fitbit was committed to delivering a platform that would enable more people to learn about their fitness.
The deal is the culmination of a collaboration between Insys and Fitbit.
“As a company, we believe that in the long run we can create an incredibly powerful platform that allows anyone to be able to learn and understand the health and wellness data that they have gathered, whether it’s from a FitBit, an iPhone or an Android device,” Horowitz said in a statement.
“As a consumer, you can then be more empowered to make informed decisions.”
Insys has been criticized by health regulators and the medical community for the use and marketing of its technology.
It was recently acquired by Samsung in a $1.2 billion transaction.